Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Alto Neuroscience, Inc. (ANRO) had Weighted-Average Shares Outstanding (Diluted) of 27.07M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-17.71M |
|
-- |
|
-- |
|
$18.68M |
|
$-18.68M |
|
$0.98M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-17.71M |
|
$-18.68M |
|
$-18.51M |
|
27.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.07M |
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$149.85M |
|
$2.31M |
|
$8.03M |
|
$157.88M |
|
$8.13M |
|
$22.12M |
|
$26.34M |
|
$34.47M |
|
$123.41M |
|
$123.41M |
|
$123.41M |
|
27.07M |
|
| Cash Flow Statement Financials | |
$-30.34M |
|
$-0.02M |
|
$9.74M |
|
$168.73M |
|
$148.09M |
|
$-20.64M |
|
$3.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.43 |
|
-- |
|
-- |
|
0.15 |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.35% |
|
-14.35% |
|
-11.22% |
|
-12.17% |
|
$4.56 |
|
$-1.12 |
|
$-1.12 |
|